Thromb Haemost 1988; 60(02): 182-187
DOI: 10.1055/s-0038-1647026
Original Article
Schattauer GmbH Stuttgart

Glycoprotein Ib Has a Partial Role in Platelet-von Willebrand Factor Collagen Interaction

Morio Aihara
The First Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan
,
Ken Tamura
The First Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan
,
Ryuko Kawarada
The First Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan
,
Keizou Okawa
The First Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan
,
Yutaka Yoshida
The First Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 21. August 1987

Accepted after revision 17. Mai 1988

Publikationsdatum:
28. Juni 2018 (online)

Summary

The adhesion of human fixed washed platelets (FWP) to collagen was decreased after treatment with Serratia marcescens protease (SP), which removed 95% of the glycocalicin from platelet membrane glycoprotein (GP) lb. However, the diminished adhesion of SP treated FWP to collagen could still be increased in the presence of purified von Willebrand factor (vWF). This ability of vWF to increase FWP adhesion to collagen is defined as collagen cofactor (CCo). The adhesion of FWP to collagen was not affected by a monoclonal antibody (MAb) to GP Ilb/IIIa (10E5), that inhibits ADP and collagen induced platelet aggregation. On the other hand, it was decreased by 50% by a MAb to GP lb (6D1), that inhibits ristocetin induced platelet aggregation. Adhesion of FWP in buffer to collagen was completely inhibited by Ricinus communis agglutinin I or concanavalin A, while Lens culinalis agglutinin and wheat germ agglutinin showed 50% inhibition. The FWP adhesion to collagen in the presence of vWF (normal plasma) was unaffected by MAbs to GP Ilb/IIIa (10E5, P2, HPL1) but was decreased to 32-38% by MAbs to GP lb (6D1, AN51, HPL11). A MAb to vWF (CLB-RAg 35), that inhibits ristocetin induced binding of vWF to platelets, decreased the CCo of normal plasma by 70%. The MAb, CLB-RAg 201, that inhibits the binding of vWF to collagen, completely inhibited the CCo of normal plasma. In conclusion, our data suggest that (1) GP lb has a partial role in FWP adhesion to collagen; (2) the binding of vWF to collagen is required for the expression of CCo; (3) CCo is partly mediated through GP lb; but (4) other platelet membrane protein(s) besides GP lb or GP Ilb/IIIa must also be involved in FWP-vWF-collagen interactions.

 
  • References

  • 1 Packham MA, Mustard JF. Platelet adhesion. (In: Progress in Hemostasis and Thrombosis; 7). Spaet TH. (ed) Grune and Stratton; Orland, FL: 1984: 211-288
  • 2 Chesterman CN, Bemdt MC. Platelet and vessel wall interaction and the genesis of atherosclerosis. Clin Haematol 1986; 15: 323-353
  • 3 Chiang TM, Kang AH. Isolation and purification of collagen alpha I (I) receptor from human platelet membranes. J Biol Chem 1982; 257: 7581-7586
  • 4 Tsunehisa S, Tsuji T, Tohyama H, Osawa T. Interaction of human platelet membrane glycoproteins with collagen and lectins. Biochim Biophys Acta 1984; 797: 10-19
  • 5 Shadle PA, Ginsberg MH, Plow EF, Barondes SH. Platelet-collagen adhesion: Inhibition by a monoclonal antibody that binds glycoprotein lib. J Cell Biol 1984; 99: 2056-2060
  • 6 Saito Y, Imada T, Takagi J, Kikuchi T, Inada Y. Platelet factor XIII. The collagen receptor?. J Biol Chem 1986; 261: 1355-1358
  • 7 Nieuwenhuis HK, Sakariassen KS, Houdijk WP M, Nievelstein PF E M, Sixma JJ. Deficiency of platelet membrane glycoprotein la associated with a decreased platelet adhesion to subendothelium: A defect in platelet spreading. Blood 1986; 68: 692-695
  • 8 Kotite NJ, Cunningham LW. Specific adsorption of a platelet membrane glycoprotein by human insoluble collagen. J Biol Chem 1986; 261: 8342-8347
  • 9 Aihara M, Cooper HA, Wagner RH. A quantitative method for studying platelet adhesion to collagen. J Lab Clin Med 1984; 103: 758-767
  • 10 Aihara M, Cooper HA, Wagner RH. Platelet-collagen interaction: Increase in rate of adhesion of fixed washed platelets by factor VIII-related antigen. Blood 1984; 63: 495-501
  • 11 Aihara M, Takami H, Sawada Y, Morimoto S, Kariya K, Kudo I, Ueno K, Kimura A, Yoshida Y. Effect of fibronectin and von Willebrand factor on the adhesion of human fixed washed platelets to collagen immobilized beads. Thromb Res 1986; 44: 661-672
  • 12 Perret BA, Furlan M, Jeno P, Beck EA. Von Willebrand factor-dependent agglutination of washed fixed human platelets by insoluble collagen isolated from bovine aorta. J Lab Clin Med 1985; 107: 244-252
  • 13 Mc Michael AJ, Rust NA, Pilch JR, Sochynsky R, Morton J, Mason DY, Ruan CR, Toblem G, Caen J. Monoclonal antibody to human platelet glycoprotein I. I. Immunological studies. Br J Haematol 1981; 49: 501-509
  • 14 Furukawa K, Hayashi K, Shiku H, Yamada K. Analysis of cell surface molecules on human platelets with monoclonal antibodies. II. Diversity of antibody-binding sites on molecules and its relation to platelet function. Acta Haematol 1986; 75: 147-152
  • 15 Mc Gregor JL, Brochier J, Wild F, Follea G, Trzeciak M, James E, Dechavanne M, Mc Gregor L, Clemetson KJ. Monoclonal antibodies against platelet membrane glycoproteins. Characterization and effect on platelet function. Eur J Biochem 1983; 131: 427-436
  • 16 Coller BS, Peerschke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest 1983; 72: 325-338
  • 17 Coller BS, Peerschke EI, Scudder LE, Sullivan CA. Studies with a monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GP lb as a platelet receptor for von Willebrand factor. Blood 1983; 61: 99-110
  • 18 Guillet JG, Hoebeke J, Cuong T, Marullo S, Strosberg D. Characterization, serological specificity and diagnostic possibilities of monoclonal antibodies against Legionella pneumophilia. J Clin Microbiol 1983; 18: 793-797
  • 19 Sixma JJ, Sakariassen KS, Stel HV, Houdijk WP M, In der Maur DW, Hamer RJ, de Groot PG, van Mourik JA. Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen. J Clin Invest 1984; 74: 736-444
  • 20 Cooper HA, Reisner FF, Hall M, Wagner RH. Effects of thrombin treatment on preparations of factor VIII and the Ca2+-dissociated small active fragment. J Clin Invest 1975; 56: 751-760
  • 21 Binnie C, Wagner RH, Cooper HA, Hermans J. Parallel characterization of bovine von Willebrand protein (factor VUI-associated protein) by light scattering and SDS gel electrophoresis. Thromb Res 1986; 40: 523-532
  • 22 Aihara M, Yoshida Y. Plasma collagen cofactor correlated with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time. Thromb Haemostas (in press)..
  • 23 Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvascular Res 1973; 5: 167-179
  • 24 Bryckaert MC, Pietu G, Ruan C, Toblem G, Girma JP, Meyer D, Larrieu MJ, Caen JP. Abnormality of glycoprotein lb in two cases of “pseudo”-von Willebrand’s disease. J Lab Clin Med 1985; 106: 393-400
  • 25 Chiang TM, Jin AI, Kang AH. Platelet-collagen interaction. Inhibition by a monoclonal antibody raised against collagen receptor. J Immunol 1987; 139: 887-892
  • 26 Connellan JM, Thurlow PJ, Barlow B, Lowe M, McKenzie IF C. Investigation of alternative mechanisms of collagen-induced platelet activation by using monoclonal antibodies to glycoprotein Ilb-IIIa and fibrinogen. Thromb Haemostas 1986; 55: 153-157
  • 27 Weiss HJ, Turitto VT, Baumgartner HR. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood 1986; 67: 322-330
  • 28 Sakariassen KS, Nievelstein PF E M, Coller BS, Sixma JJ. The role of platelet membrane glycoproteins lb and Ilb-IIIa in platelet adherence to human artery subendothelium. Br J Haematol 1986; 63: 681-691
  • 29 Clemetson KJ. Glycoproteins of the platelet plasma membrane. In: Platelet membrane glycoproteins. George JN, Nurden AT, Phillips DR. (eds) Plenum; New York, NY: 1985: 51-85
  • 30 Pietu G, Fressinaud E, Girma JP, Nieuwenhuis HK, Rothschild C, Meyer D. Binding of human von Willebrand factor to collagen and to collagen-stimulated platelets. J Lab Clin Med 1987; 109: 637-646
  • 31 Laduca FM, Bell WR, Bettigole RE. Platelet-collagen adhesion enhances platelet aggregation induced by binding of vWF to platelets. Am J Physiol 1987; 253: H1208-H1214
  • 32 Santoro SA, Cunningham LW. Platelet-collagen adhesion – Membrane fluidity and the development of high affinity adhesion through multiple interacting sites. Collagen Rel Res 1981; 1: 517-526
  • 33 Sugiyama T, Okuma M, Ushikubi F, Sensaki S, Kanaji K, Uchino H. A novel platelet aggregating factor found in a patient with defective collagen induced platelet aggregation and autoimmune thrombocytopenia. Blood 1987; 69: 1712-1720